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Abstract
Neutrophils are recruited to sites of injury but their timely removal is thought to be vital to prevent
exacerbating inflammation. In addition, the recognition of apoptotic cells by cells of the innate
immune system provides potent anti-inflammatory and anti-immunogenic signals. In this paper we
describe how human neutrophils dying by apoptosis or necrosis release anti-inflammatory
peptides, the alpha defensins. This family of small cationic peptides, effectively inhibits the
secretion of multiple pro-inflammatory cytokines and nitric oxide from macrophages, the main
innate immune cell found at sites of chronic inflammation. In addition, the systemic administration
of necrotic neutrophil supernatants and alpha defensins protects mice from a murine model of
peritonitis. Hence their effects may be far reaching and serve to kill microbes whilst regulating a
potentially tissue destructive inflammatory response.
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Introduction
Polymorphonuclear cells (PMNs) are the most abundant type of leukocyte, rapidly recruited
to sites of inflammation by pathogen-derived stimuli or host derived danger signals (1).
Subsequent activation of PMN triggers the release of reactive oxygen species and an arsenal
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of non-specific cytotoxic compounds. This has led researchers to consider that the safe
disposal of neutrophils as early as possible is essential to the maintenance of immunological
homeostasis and the resolution of inflammation (2). However the data that exposes the
pathogenic role of late apoptotic and necrotic neutrophils is conflicting. Elastase, which is
released by necrotic neutrophils, has been reported to induce resting macrophages to secrete
pro-inflammatory cytokines (3). In contrast, other studies indicate that necrotic neutrophils
are phagocytosed by macrophages in a non-phlogistic manner and even down regulate
CD80, CD86 and CD40 on immature DC, rendering them unable to induce T cell
proliferation in an MLR (4, 5). In addition whilst necrotic cell lines are able to induce DC
maturation, necrotic primary cells are not (6-8), suggesting that necrotic cells cannot by
themselves be considered dangerous, without reference to the cell type and the way in which
they are exposed to the immune system.
Defensins are widely distributed in nature, being expressed by leukocytes and epithelial cells
lining the environmental interface. They are divided into alpha and beta defensins based on
their tertiary structure, which has a characteristic six cysteine motif; pairing to form three
intramolecular disulphide bonds. α-Defensins are small cationic and amphipathic peptides
with a molecular weight of 3–5 kDa (9). Of the six α-defensins, four (HNP1-4) are major
constituents of human neutrophils, where they are found stored in the azurophilic (primary)
granules. The other two (HD5-6) are expressed in the Paneth cells, which are secretory
epithelial cells located in the small intestinal crypts (10). Whilst rats and rabbits express
neutrophil α-defensins, mice do not; but they do express homologues of human HD5-6 in
the Paneth cells, known as cryptidins (11). The secretion of α-defensins by epithelial cells is
an important component of innate immunity. This is highlighted by mice that lack
matrilysin-7 and cannot secrete active cryptidins, due to an inability to process Paneth cell
α-defensin precursors. Despite the fact that they secrete a number of other antimicrobial
molecules they are more susceptible to an oral challenge with a virulent strain of S.
typhimurium and mount a more severe inflammatory response (11). In contrast mice
transgenic for the human crypt α-defensin, HD-5, are protected from a normally lethal dose
of Salmonella (12). Recently α-defensins have been reported to block the release of IL-1β
from monocytes whilst having no effect on the release of TNF-α (13). Monocytes, which
are found circulating in the blood, mature into macrophages upon egress from the circulation
and entry into tissues. Here they interact with activated neutrophils in the absence of serum
proteins that are known to inhibit α-defensin function (14, 15). In this paper we describe
how α-defensins, released by dying and necrotic neutrophils exert a powerful anti-
inflammatory effect on human macrophages whilst still maintaining significant anti-
microbial activity.
Materials and Methods
Reagents
Purified HNP1-3 was supplied by Hycult biotechnology. Synthetic HNP1, linearized HNP1
and the D enantiomer of HNP was kindly provided by Prof Wuyuan Lu. Linear (or
linearized) HNP1 is an unstructured form of the α-defensin, in which the six Cys residues
have been replaced by Ala. LL-37
(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES; MW 4493.33) was synthesized
by N-(9-fluorenyl) methoxycarbonyl chemistry at the Nucleic Acid/Protein Service unit at
the University of British Columbia (UBC; Vancouver, Canada), as described previously
(Barlow et al, J. Leuk. Biol, 1996, 80:509-520). R-roscovitine, (R)-2-[[9-(1-methylethyl)-6-
[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol (A.G. Scientific) was kindly
provided by Prof A. Rossi and used at 20uM. HMDMs were stimulated with CD40 ligand
(Peprotech, UK) at 3ug/ml and IFN-γ (Peprotech, UK) at 5ng/ml. LPS (Sigma) was used at
1ng/ml.
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Mice
6-8 week old female C57BL/6, mice (Harlan-UK), were used at 8-9 weeks of age and were
sex and age-matched within experiments. All experiments were covered by a Project
License granted by the Home Office under the Animal (Scientific Procedures) Act 1986.
Locally, this license was approved by the University of Edinburgh Ethical Review
Committee.
Generation of apoptotic cells
Human neutrophils were extracted from peripheral blood of healthy volunteers, as described
previously (16). Blood was separated using dextran sedimentation and a Percoll gradient.
This yielded highly pure human neutrophils (>95%). Neutrophils were cultured in serum
free IMDM supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 ug/ml
streptomycin for various periods of time and the cell free medium collected and
ultracentrifuged at 100,000g for 1 hour prior to using immediately or storing at −70°C.
Necrotic neutrophils were generated from freshly isolated neutrophils by freeze thawing
them 5 times after which no complete cells remained. Membranes were removed by
ultracentrifuging them at 100,000g for 1 hour. In all in vitro experiments the number of
neutrophils used was 12 × 106/ml. An equivalent number of necrotic neutrophils were
generated by freeze thawing per ml of culture medium and the membrane free supernatant
was used at this concentration. Necrotic thymocytes were generated from thymi removed
from 6 week old syngeneic mice, teased into single cell suspensions and freeze thawed 5
times as described for necrotic neutrophils. Murine neutrophils were isolated from the bone
marrow of syngeneic mice by percoll gradient and then treated in the same way as human
neutrophils to obtain necrotic membrane free cell fractions at the same concentration.
Macrophage culture
Human monocytes were extracted from peripheral blood of healthy volunteers according to
Lothian Research Ethics Committee approval (LREC/2001/4/56), using dextran
sedimentation and a Percoll gradient as previously described (16). They were cultured in
IMDM supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin,
and 10% autologous platelet-rich plasma-derived serum. Mature macrophages were used on
day 7. Murine bone marrow derived macrophages were cultured, as described previously (4)
and used between day 7 and 10 of culture. All assays were done in serum free medium.
Depletion of α-defensins using R2 or dynabeads beads
R2 beads (Applied Biosystems), which bind hydrophobic proteins, were incubated with
membrane free necrotic neutrophil supernatants for 2 hours. Beads were then removed
following centrifugation and proteins in the supernatant or on the beads was analysed by
NuPage 10% Bis-Tris gel with MES running buffer, Invitrogen. Proteins were visualized by
silver stain. The band of peptides at 3-5 kd was cut out, reduced, alkylated and digested with
trypsin. Chromatographic separation of tryptic digests was conducted by an Ultimate 3000
nanoLC system (Dionex, Mountain View, CA) and peptides were analyzed by an HCT Ultra
PTM ion trap instrument (Bruker Daltonics) equipped with a nano-ESI source. Acquired
spectra were analyzed using the MASCOT search engine (Matrix Science) (D. Compopiano
and D. Clarke-University of Edinburgh). To specifically deplete NN of α-defensin,
Dynabeads M280 coated with sheep anti mouse IgG (Invitrogen) were bound to mouse anti-
human HNP 1-3 (Hycult) as per the manufacturers instructions. These anti-HNP 1-3 coated
beads were then used to deplete NN of α-defensin and beads with bound α-defensin were
removed with a magnet (BD Pharmingen). Complete and specific depletion of α-defensin
was checked both by HNP 1-3 ELISA (Hycult) and by protein gel.
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Tests of cell viability
LDH released from the cytoplasm of dying macrophages into the assay medium was used as
a measure of membrane integrity and viability. A cell cytotoxicity colorimetric kit was used
according to the manufacturers instructions (Sigma Aldrich) The assay utilizes NAD,
reduced by the released lactate, which induces a colour change in a tetrazolium dye that can
be detected using a spectrophotometric method. As a positive control the protein synthesis
inhibitor cyclohexamide (10ug/ml) was used to reduce cell viability after 24 hours. The
Alamar Blue assay is a sensitive non-radioactive means of measuring cell viability based on
the addition of a fluorogenic redox indicator to cells in culture. When taken into cells,
Alamar Blue becomes reduced and turns red. This reduced form of Alamar Blue is highly
fluorescent. The extent of this conversion, which is a reflection of cell viability, was
quantified by its optical density. Alamar Blue was used at a 1:10 dilution and added to the
assay medium for the duration of the culture.
Eating assay
Cells were pretreated with α-defensin or a positive control puromycin known to reduce cell
viability (Sigma /Aldrich at 50ug/ml). After 24 hours the HMDMs were washed and fresh
medium containing 1.25×106 flourscent beads (Fluoresbrite Plain YG 3.0 micron
microspheres; PolySciences, Inc. warrington, PA) was added per 0.5×106 HMDMs. After 1h
unbound cells were removed and cells washed ×3 with PBS containing magnesium and
calcium. Cells were removed from the wells using Trypsin/EDTA, washed again and
resuspended in FACs buffer (PBS + 2% FCS) prior to analysis on a FACs machine.
Sterile Peritonitis
Peritonitis was induced by i.p. injection of 0.5 ml of 10% thioglychollate. Mice underwent
peritoneal lavage at various time points following thioglychollate injection.
Bacterial in vitro and in vivo infections of macrophages
Murine BMDM were cultured as described above. Salmonella enterica serovar
Typhimurium strain SL3261 (17), which was live or had been heat killed was added to
murine BMDM at an MOI (multiple of infection) of 10:1 bacteria to macrophages. After 1
hour excess bacteria were washed away and Gentamicin at 100ug/ml was added for 1 hour
to kill any residual extracellular bacteria. Cells were washed again and HNP1 or medium
alone was added for various time-points after which supernatants were collected for
cytokine estimation prior to lysing the macrophages with 1% Triton X for 15 minutes. Lysed
cells containing live bacteria were collected and plated onto agar and incubated for 18 hours
after which colonies were counted. In a similar way Pseudomonas Aeruginosa PA01 was
added to HMDM at an MOI of 10. After 4 hours supernatants were collected prior to lysing
the cells with 0.1% Triton X and the number of live colonies counted after a further 18 hours
of culture.
ELISA
Supernatants collected after specified culture periods were analyzed for production of
cytokines by a sandwich ELISA according to the manufacturers instruction (R&D systems,
UK). HNP 1-3 was measured using an HNP1-3 ELISA according to the manufacturers
instructions (Hycult Biotechnology). All experiments were performed in triplicate.
Statistics
Data are expressed, when appropriate, as mean and SEM. Significance was assessed using
unpaired t tests, and p-values <0.05 were considered significant.
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Results
Apoptotic neutrophils do not require contact to inhibit inflammatory macrophages
Our interest in a soluble factor released by dying human neutrophils was initiated by the
observation that co-culture of apoptotic neutrophils separated from activated human
monocyte derived macrophages (HMDMs) by transwells led to the inhibition of pro-
inflammatory cytokine secretion (Fig 1 a/b). TGF-β is thought to play a pivotal role in the
inhibition of HMDM TNF-α secretion by apoptotic neutrophils (18). However the addition
of blocking anti-TGF-β to apoptotic neutrophils, in contact with LPS-stimulated HMDM
had only a moderate inhibitory effect but no effect on CD40L/IFN-γ stimulated HMDM.
Apoptotic cells generate apoptotic bodies (19), which may be able to pass through the pores
of a transwell. To control for this we ultra-centrifuged supernatants derived from neutrophil
cultures to remove apoptotic bodies and all membrane constituents. The active inhibitory
factor contained within this neutrophil-conditioned medium (NCM) was released by dying
neutrophils in a time-dependent manner. It was able significantly to inhibit the secretion of
TNF-α from macrophages stimulated by both LPS and CD40L/IFN-γ by 4 hours after
culture, when neutrophils are beginning to undergo apoptosis (Fig 1c/d). TGF-β measured in
supernatants from CD40L/IFN-γ- and LPS-stimulated HMDM was not significantly raised
whilst levels of IL-1β, IL-6, IL-8 and IL-10 and nitric oxide were all decreased (data not
shown).
To ask if neutrophil apoptosis augmented the release of the soluble factor we cultured
neutrophils in the presence of R-roscovitine, which is known to induce neutrophil apoptosis
(20). Following 6 hours of culture the percentage of neutrophils positive for annexin-V
increased from 14% to 56.4% (Fig 2a). R-roscovitine did not itself inhibit TNF-α secretion
from LPS-stimulated HMDMs (Fig 2b). However culture supernatants from R-roscovitine-
treated neutrophils inhibited pro-inflammatory cytokine secretion significantly more than
untreated NCM (Fig 2b-c). In contrast, if apoptosis was inhibited, (by culturing neutrophils
at 4°C overnight) (Fig 2d) the ability of the NCM was lacking in anti-inflammatory activity.
If the same neutrophils were then allowed to undergo apoptosis for 6 hours by culturing at
room temperature the inhibitory factor was released into the NCM (Fig 2e).
Necrotic neutrophils are also anti-inflammatory
We wondered whether primary or secondary necrotic neutrophils would also release the
active immunosuppressive factor. To generate necrotic neutrophils we freeze thawed fresh
neutrophils 5 times after which more than 90% of the neutrophils had lysed (data not
shown). These lysed cells were then ultracentrifuged to remove membranous material and
the remaining necrotic neutrophil conditioned medium (NN) added to LPS stimulated
macrophages. Titration of the NN revealed a dose dependent inhibition of TNF-α secretion
by the activated macrophages, which was even more effective than using NCM at the same
dilution (Fig 3a). The TNF-α ELISA was able to detect both mature and precursor TNF-α.
In addition, TNF–α converting enzyme (TACE) levels were measured and found to be
unchanged (data not shown). Multicytokine analysis confirmed that NN was also able to
inhibit the production of cytokines including IL-6, IL-1β, IL-8, and IL-1 (Fig 3b). In
addition NN also inhibited the generation of nitric oxide (Fig 4c). The concentration of
TGF-β was either decreased or similar to stimulated cells (data not shown). Identical results
were obtained using NN prepared from secondarily necrotic neutrophils that had previously
undergone 24 hours of culture (data not shown).
Necrotic neutrophils but not other necrotic cells are anti-inflammatory
Necrotic cells are generally considered to pose a danger to the immune system resulting in
auto-antibody generation and a breakdown in tolerance to self with subsequent
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autoimmunity (21-23). We were interested to know if necrotic neutrophils were unique in
their ability to release a soluble anti-inflammatory factor or if this could be generalised to
other primary cells or tumour cell lines. The anti-inflammatory activity of necrotic
neutrophils was compared to supernatants from necrotic murine thymocytes (NT) and from
the necrotic human tumour cell line, Mutu (NM). While necrotic thymocyte supernatants
had a limited ability to suppress TNF-α secretion from LPS-stimulated HMDM, necrotic
tumor cells had none (Fig 4a) and both necrotic thymocytes and tumour cells were pro-
inflammatory to CD40L/IFN-γ-stimulated HMDMs (Fig 4b). In contrast NN was markedly
anti-inflammatory inhibiting both TNF-α and nitric oxide (NO) generation (Fig 4c/d). This
indicates that compared to the cells tested, the release of a soluble anti-inflammatory factor
is specific to neutrophils.
Alpha defensins are the active anti-inflammatory factor released by apoptotic/necrotic
neutrophils
To delineate further the active immunosuppressive factor we tested the NN that had been
depleted of hydrophobic proteins using R2 beads and found that depleted NN now lacked
the ability to inhibit LPS (Fig 5a) or CD40L/IFN-γ (Fig 5b) stimulated HMDM release of
TNF-α. The R2 beads had partially removed a range of proteins from the NN, but
completely removed a band of proteins between 3-5kDa in size (Fig 5c). This band was
digested and sequenced by MS/MS and found to be the anti-microbial peptide α-defensins
(data not shown). When purified alpha defensins (AD) were added back to the R2 depleted
NN the immunosuppressive activity of the NN was restored, indicating that one of the active
inhibitory factors released by and contained within the neutrophils was α-defensins.
However R2 beads removed a range of proteins from the NN and to ensure specificity, α-
defensins were depleted from NN using anti-human HNP 1-3 bound to dynabeads. The
complete removal of α-defensins was confirmed with an HNP1-3 ELISA whilst the
specificity of the antibody bound beads was confirmed by protein gel analysis (data not
shown). When α-defensins were specifically depleted from the NN the ability of NN to
inhibit TNF-α production by CD40L/IFN-γ stimulated HMDMs was completely lost (Fig
5di), but was regained upon addition of HNP-1. However NN was still able to significantly
inhibit TNF-α production by HMDMs stimulated with LPS (Fig 5dii) because the NN
retained LL37, which is known to bind to LPS and inhibit its pro-inflammatory potential
(24). When HNP-1 was added back though the full inhibitory capacity of the NN was
restored.
α-Defensins exist as 4 types in human neutrophils; human neutrophil peptides 1-4
(HNP1-4). HNP1-3 constitute more than 5% of the total cellular protein in human
neutrophils and 99% of the total defensin content of neutrophils with traces of HNP4. We
measured HNP1-3 released by neutrophils undergoing apoptosis in culture and found that
the concentration of HNP1-3 increased progressively with time reaching a peak by 9 hours
suggesting that the release of α-defensins is associated with ongoing neutrophil apoptosis
(Fig 5e). The level of the α-defensins in necrotic neutrophil supernatants was consistently
higher at between 8-15 +/− 0.45 ug/ml, depending on the human donor. We also assessed
the concentration of HNP 1-3 in the synovial fluid of 12 patients suffering with a flare of
rheumatoid arthritis undergoing arthrocentesis for an acutely swollen knee, which was found
to range between 3-25ug/ml with an average of 12.4ug/ml indicating that the concentration
reached in tissues is not dissimilar to that tested in our assays.
α-Defensins do not kill macrophages
A number of reports have described how α-defensins are able to kill eukaryotic cells
reviewed in (25). In contrast, L929 cells a murine fibroblast cell line, is resistant to killing
by α-defensins (26). We asked if α-defensins decreased the cytokine production of
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macrophages through a delayed effect on cell viability. We found that α-defensin (25ug/ml)
pre-treatment for 1 hour prior to stimulating HMDMs with LPS inhibited the ability of
macrophages to generate TNF-α, but 20 hours following the removal of α-defensins they
were able to secrete equivalent amounts of TNF-α when compared to untreated control
macrophages (Fig 6ai). In addition HMDMs cultured in the presence of α-defensin for 24
hours were more refractory to stimulation with LPS and only fully recovered their ability to
secrete TNF-α after 72 hours (Fig 6aii). However the fact that they do completely recover
indicates that α-defensin treated macrophages, (which do not proliferate in culture) are still
viable and able to respond to LPS as well as control cells after a period of time. In addition
we performed LDH assays to assess the viability of macrophages after α-defensin treatment.
Lactate dehydrogenase (LDH), which is released as cells die, was not significantly elevated
when compared to both resting and CD40L/IFN-γ stimulated HMDMs (Fig 6b) after 24
hours of culture with α-defensins. We utilised an additional test of cell viability, the Alamar
Blue assay, which relies on detecting the reduced form of Alamar Blue generated by
reductase enzymes present in viable cells. When cells were cultured in the presence of the
cytotoxic agent, puromycin for 24 hours and then stimulated with LPS a definite decrease in
the reduction of Alamar blue is seen secondary to a reduction in cell viability. In contrast no
change in reductive capacity is seen in HMDMs pretreated with α-defensin (25ug/ml) for
the same length of time indicating that viability was maintained (Fig 6c). Finally we
assessed the other main function of HMDMs, their ability to phagocytose (beads) following
pre-treatment for 24 hours with either α-defensin or puromycin (Fig 6d). In comparison to
control untreated HMDMs (6ci) puromycin treated HMDMs showed a reduction in the
ability to phagocytose fluorescent beads (6cii); but HMDMs pre-treated with α-defensins
had a significantly augmented phagocytic capacity when compared to untreated
macrophages (6ciii), suggesting that α-defensins had functionally altered the macrophage to
a pro-resolution, pro phagocytic phenotype.
Alpha defensins inhibit the pro-inflammatory cytokine production by macrophages in the
presence of both live and dead whole bacteria
We went on to ask if α-defensins were able to inhibit macrophage pro-inflammatory
function and still inhibit the growth of bacteria. We first looked at the response of HMDMs
to infection with the human opportunistic pathogen Pseudomonas Aeruginosa PA01.
HMDMs infected with live bacteria (Fig 7ai) at a MOI of 10 and treated with α-defensins or
with an equivalent number of dead whole bacteria (Fig 7aii) also showed an inhibited
secretion of TNF-α, IL-8, IL-6 and IL-1β. In spite of the reduced pro-inflammatory cytokine
secretion bacterial counts were not increased when compared to control infected HMDMs
(Fig 7b). Hence α-defensin treatment inhibits an excessive pro-inflammatory cytokine
response from the HMDM despite the presence of both live and dead Pseudomonas
Aeruginosa PA01, but this does not subsequently allow for excessive pathogen replication.
We went on to ask if α-defensins could affect a murine model of infection. We used the
murine pathogenic Salmonella enterica serovar Typhimurium strain SL3261 to infect mice
and sacrificed them on day 7 at the height of infection (Fig 7c). We found that the
administration of NN had a significant effect on reducing bacterial counts in the spleen (7ci)
and also reduced TNF-α in the serum (7cii).
Alpha defensins but not LL37 inhibits both T cell mediated and LPS mediated activation of
macrophages
Neutrophils contain within the secondary granules cathelicidin, an anti microbial peptide of
comparable electrophorectic mobility to α-defensins. LL37, the active fragment of the only
human cathelicidin hCAP-18 is known to bind LPS and inhibit LPS mediated activation of
macrophages (24, 27). To test the possibility that one of the inhibitory factors contained
within the NN was LL37 we titrated LL37 into both LPS (Fig 8a) and CD40L/IFN-γ (Fig
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8b) stimulated HMDMs and compared this with the ability of apoptotic neutrophils (N) or
NN to inhibit TNF-α secretion. Whereas LL37 was able to inhibit TNF-α secretion from
LPS activated HMDMs, it behaved as a pro-inflammatory peptide to CD40L/IFN-γ
stimulated HMDMs. This indicates that LL37 is not the active factor that inhibits both
CD40L/IFN-γ and LPS stimulated macrophages. We titrated purified HNP 1-3 into LPS
(Fig 8c) or CD40L/IFN-γ (Fig 8d) stimulated HMDMs and found that this peptide
preparation was able to significantly inhibit pro-inflammatory cytokine secretion by
activated HMDMs. As HNP1 constitutes the major alpha defensin in the primary granules of
neutrophils (25) we used synthetically-derived HNP-1, finding similar levels of
immunosuppressive activity (Fig 8e). HNP2 and HNP3 were also able to significantly
inhibit TNF-α secretion by LPS or CD40L/IFN-γ stimulated HMDMs (data not shown).
The requirement for structural integrity of HNP1 was examined by comparing the ability of
linearized α-defensin, to inhibit TNF-α secretion from CD40L/IFN-γ. HMDMs; this
confirmed that the three dimensional structure of HNP-1 was essential for anti-inflammatory
activity, which was completely lost when the peptide was linearized (Fig 8f).
Alpha defensins do not affect the release of pro-inflammatory cytokines from
macrophages
We asked if α-defensins elicited their anti-inflammatory properties via a direct effect on cell
membranes preventing the release of cytokines contained within secretory vesicles of
HMDMs. To address this we stimulated mature HMDMs with CD40L/IFN-γ plus or minus
HNP1-3. At specified time-points culture supernatants were collected and analysed for TNF-
α protein by ELISA. TNF–α levels climbed steadily after stimulation in control wells
reaching a peak after 8 hours. However in stimulated and HNP1-3 treated wells TNF-α
appeared to plateau soon after 3 hours and remained low for the duration of the experiment
(Fig 9a). To ask if the TNF-α may be prevented from leaving the cells, macrophages were
lysed at 4 hours after stimulation. The concentration of cytokines contained within the
macrophage (Fig 9bi) and secreted into the culture medium was then compared by ELISA
(Fig 9bii). No significant differences were seen in the ratio of secreted to retained TNF-α in
either LPS or CD40L/IFN-γ stimulated HMDMs treated with α-defensins suggesting that
TNF-α was not being sequestered within the macrophage. The low levels of NO found after
α-defensin treatment would also be in keeping with our data as this is not stored in secretory
vesicles (Fig 4c/d).
Necrotic neutrophils and HNP-1 protect mice from experimental inflammation
To assess the local effect of α-defensins on an established inflammatory response in vivo we
used the thioglychollate model of peritonitis and found HNP1 and NN reduced the cellular
infiltrate of neutrophils and macrophages (Fig 10a). We did not find a significant reduction
in the inflammatory cell influx using necrotic mouse neutrophils (prepared in an identical
way to human NN and at the same concentration), which lack α-defensins nor did the
injection of whole AC or LL37 at 5 ug/ml affect the accumulation of inflammatory cells. In
separate experiments to test the possibility that the reduced influx of inflammatory cells was
secondary to the inhibition of resident peritoneal macrophages, these cells were isolated
from the peritoneum of untreated mice, adhered to plastic overnight and stimulated with
CD40L/IFN-γ along with added α-defensins (Fig 10b). Resident peritoneal macrophages
treated with α-defensin were completely unable to respond to the stimulus and secrete TNF-
α. Identical results were obtained following LPS stimulation (data not shown).
Discussion
It is currently widely believed that macrophages must engulf apoptotic neutrophils before
they become necrotic to prevent the release into the tissues of potentially toxic and
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immunogenic intracellular substances (28). We have now discovered that both apoptotic and
necrotic neutrophils elicit a profound anti-inflammatory response in macrophages that does
not require cell contact. We have identified the anti-inflammatory mediator they release as
α-defensins. The α-defensins inhibit macrophage pro-inflammatory function driven both by
the microbial cell wall constituent LPS and a T cell surrogate stimulus CD40L/IFN-γ. When
HMDMs are infected with Pseudomonas α-defensins effectively prevented the macrophages
from inducing an exaggerated pro-inflammatory cytokine response, whilst not
compromising the ability of macrophages to keep bacterial viability in check. This was
mirrored in an in vivo model of infection with the pathogenic Salmonella Typhimurium
using NN where both bacterial cell counts and serum TNF-α measured at the height of the
infection were reduced.
Alpha-defensins are released by neutrophils as early as 4 hours after in vitro culture and
continue to be released reaching a peak when neutrophil apoptosis is established.
Importantly, the α-defensins are also released from necrotic cells when they disintegrate,
explaining the protective effect of necrotic neutrophils when injected in vivo in a murine
model of inflammation and infection. The finding that human NN, (which contains α-
defensins) were able to reduce the influx of neutrophils and inflammatory macrophages in a
murine model of peritonitis was surprising given that they have been shown to be
chemotactic for immature dendritic cells and lymphocytes, though interestingly do not
activate them (29). In addition necrotic human neutrophil supernatants were devoid of
membranous products (following ultracentrifugation) but were otherwise replete with
preformed enzymes that would be expected to be pro-inflammatory in their own right (1, 3).
In contrast murine necrotic neutrophils, which do not contain α-defensins but are otherwise
similar to human neutrophils did not affect the influx of inflammatory cells into the
peritoneum suggesting that this effect was specific for the presence of the peptide (30). The
effect of α-defensins on macrophages may be specific as α-defensin treatment did not
inhibit the activation of human neutrophils by TNF-α, as measured by the loss of surface
CD62L (L-selectin) and CD11b upregulation. Myeloperoxidase release from these activated
neutrophils and the degranulation of murine peritoneal mast cells was also unaffected (data
not shown). One may speculate that the reduced influx of inflammatory cells in the
peritoneum may relate to an initial dampening of the inflammatory response of resident
macrophages normally seen when the irritant and innate immune stimulus, thioglychollate is
administered. This in turn would lead to a reduction in cellular influx of neutrophils and
inflammatory macrophages. In support of this, in vitro experiments on resting resident
peritoneal macrophages that have been stimulated with α-defensins show that they are
completely inhibited from responding to concomitant stimulation with CD40/IFN-γ and this
inhibition may override any chemotactic effect of α-defensin alone. α-Defensins have
recently been shown to inhibit specifically the secretion of IL-1β by monocytes attesting to
their anti-inflammatory role (13). Interestingly recent reports have linked the absence of
intestinal Paneth cell α-defensins to chronic colitis seen both in animal models and in
humans with Crohn’s disease (11, 31). As Crohn’s disease is likely due to an aberrant
response to commensal bacteria which normally pose no risk to healthy adults (32-34), one
could speculate that the lack of these α-defensins may deprive these patients not only of an
antimicrobial peptide but also of an important anti-inflammatory and immuno-regulatory
signal in the distal small intestine (13). Indeed the effect of α-defensins on macrophages,
reducing the secretion of multiple pro-inflammatory cytokines whilst checking the growth of
bacteria attests to its ability to prevent an excessively pro-inflammatory macrophage
response whilst not sacrificing its ability to function as an antimicrobial peptide. The
mechanism by which α-defensins inhibit such a broad swathe of pro-inflammatory
cytokines and NO is unknown. As an anti-microbial peptide, they induce pores in bacterial
membranes but the exact means by which they kill microbes remains a mystery (35).
Analysis of treated macrophages used in our assays showed no evidence of macrophage
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apoptosis following culture with α-defensins. Prolonged treatment for up to 24 hours with
α-defensins did not result in a delayed decrease in viability as measured by Alamar blue and
LDH assays. In addition macrophages regained the ability to respond to pro-inflammatory
stimuli producing equivalent amounts of TNF-α, compared to control untreated
macrophages following a delay that was proportional to the time that they had been initially
exposed to α-defensins. Pre-treatment with α-defensins led to an increase in phagocytic
capacity, which suggests that they do not simply inhibit macrophage function but alter it to a
pro-phagocytic pro-resolution phenotype. Time-course studies of secreted TNF-α indicate
that released cytokine fails to ever reach control levels following α-defensin treatment but
lysates of cells did not contain TNF-α, suggesting that it was not prevented from leaving the
cells as Shi et al have found specifically for IL-1β in monocytes. We would speculate that
α-defensins may affect the translation of pro-inflammatory cytokines through an effect on
mRNA stability or alternatively through the inhibition of the pro-inflammatory transcription
factor, nuclear factor-kB. Future work clearly needs to elucidate the molecular mechanism
by which they inhibit the inflammatory phenotype of macrophages and to ask if this could
be useful as a therapeutic option in autoimmune diseases such as rheumatoid arthritis in
which the inflammatory macrophage mediates the final assault on normal healthy tissue.
Currently, the prevailing view is that necrotic cells present danger signals to the immune
system; for instance necrotic fibroblasts are found to be immunostimulatory to DC (36, 37).
Thus, it is generally accepted that the presence of necrotic cells, especially neutrophils, is
pro-inflammatory (3, 28). This is despite reports of the inhibitory effect of necrotic
neutrophils on dendritic cell (DC) maturation and the ability of macrophages to respond to
necrotic neutrophils in a non-phlogistic way, (4, 38). It seems likely that not all necrotic
cells pose a danger. Our data clearly shows that necrotic human neutrophils are, in fact, anti-
inflammatory and if a macrophage encounters such a cell its ability to secrete pro-
inflammatory cytokines and NO is inhibited, whilst its ability to phagocytose material is
increased. Thus, neutrophil necrosis at sites of inflammation far from driving the process,
initiates its resolution.
Tissue resident macrophages are among the first cells to detect microorganisms that have
crossed an epithelial barrier. They then recruit large numbers of neutrophils, followed by
blood monocytes that differentiate into macrophages upon entry into the affected tissue.
Both cell types become activated, phagocytose microorganisms and in the case of
neutrophils then undergo apoptosis. The presence of these apoptotic cells then alters the
macrophage response, switching it from an inflammatory to a pro-resolution phenotype (39).
If necrotic neutrophils were pro-inflammatory and if the ability of macrophages to
phagocytose them was overwhelmed even temporarily; then the inevitable result would be
further inflammation. In this scenario the immune system would be permanently poised on a
knife-edge, dependent entirely upon the rate at which apoptotic neutrophils were removed.
In our model, the finding that necrotic human neutrophils are uniquely anti-inflammatory
attests to the importance of avoiding this catastrophic possibility. In fact during an
inflammatory response the apoptosis of neutrophils (and subsequent interaction with
macrophages), is correlated temporally with the resolution of inflammation (40, 41).
Physiologically, α-defensins released by dying neutrophils may then exert potent anti-
inflammatory effects on macrophages, providing the perfect counterbalance to the arsenal of
cytotoxic compounds contained within them. The release of alpha defensins means that the
pro-resolution effect of apoptotic/necrotic neutrophils on inflammatory macrophages is not
limited to those cells the neutrophil specifically contacts. In conclusion, neutrophils secrete
both an antimicrobial and an anti-inflammatory peptide as they die and undergo necrosis, so
that even in death they continue to exert an immunomodulatory and anti-microbial
phenotype fighting pathogens whilst preventing an excessive inflammatory response that
would place healthy tissue at risk of further damage.
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Figure 1. Neutrophils secrete a soluble anti-inflammatory factor
(a+b) HMDM were stimulated with either LPS or CD40L/IFN-γ (CI) along with added
apoptotic neutrophils (LPSN or CIN) for 18 hours, prior to harvesting culture supernatants
for assay of TNF-α by ELISA. In triplicate wells anti-TGFβ was added to assess the role of
TGFβ in mediating the immunosuppressive effect of apoptotic neutrophils [LPSN(anti-
TGFβ) or CIN(anti-TGFβ)]. In addition apoptotic neutrophils were separated from activated
HMDM by a transwell [LPS(N) or CI(N)] for the duration of the culture period.
Macrophages alone (M) or unstimulated macrophages cultured with apoptotic neutrophils
(MN) did not secrete TNF-α.
(c+d) Neutrophils were cultured for up to 24 hours, harvested at set timepoints and
ultracentrifuged to remove cell membranes and apoptotic bodies. This neutrophil
conditioned medium (NCM) was added (as 25% final vol) to LPS or CD40L/IFN-γ (CI)
stimulated macrophages. After 18 hours of culture HMDM culture supernatants were
harvested and assayed for TNF-α by ELISA.
Representative of 10 experiments performed with different human donors. Error bars
represent SEM and significance of *** p ≤0.0002, ** p ≤0.002, * p ≤0.02.
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Figure 2. Neutrophils release an active anti-inflammatory factor as they become apoptotic
(a-i-ii) Facs analysis of neutrophils cultured in 20uM Roscovitine (Rosco) for 6 hours and
stained with Annexin V/PI to detect apoptotic and necrotic cells respectively. NCM from
neutrophils cultured with or without Roscovitine for 6 hours was co-cultured with either CI
(b) or LPS (c) stimulated macrophages for 18 hours after which macrophage culture
supernatants were collected and tested for TNF-α content by ELISA. (d) FACS analysis of
neutrophils stained with Annexin V/PI in which apoptosis was inhibited by culturing them at
4°C overnight (NCM 4°C) and then allowed to undergo apoptosis for 6 hrs by culturing at
37°C (NCM 4°C+6hr). Analysis of the ability of NCM from these 3 neutrophil populations
to inhibit LPS activated HMDM cytokine secretion was assessed by ELISA following an 18
hour incubation with LPs stimulated macrophages (e). Data representative of 3 separate
experiments with different donors. Error bars=SEM and **=p<0.02.
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Figure 3. Necrotic neutrophils are anti-inflammatory
(a) Fresh neutrophils were freeze thawed and then ultracentrifuged to generate membrane-
free necrotic neutrophil supernatants (NN). NN was titrated into cultures containing LPS
activated HMDMs. This was compared with the ability of NCM at a final vol:vol of 25%
released from apoptotic neutrophils to inhibit TNF-α secretion. TNF-α in the supernatants
collected from these stimulated macrophages (after 18 hrs of culture) was quantified by
ELISA.
(b) Multicytokine analysis of these supernatants to show that NN inhibited the secretion of a
wide range of pro-inflammatory cytokines as well as IL-10 by activated macrophages
stimulated with LPS or CD40L/IFN-γ (CI). *** p ≤0.0002, ** p ≤0.003, * p ≤0.03.error
bars =SEM. Experiments representative of 1 from 5 using separate donors.
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Figure 4. Necrotic neutrophils but not other necrotic cells are anti-inflammatory
Apoptotic neutrophils (N), necrotic neutrophil supernatants (NN), necrotic thymocyte
supernatants (NT) and necrotic supernatants from the tumour cell line Mutu (NM) were
added to either LPS (a) or CD40L/IFN-γ (CI) (b) stimulated macrophages and culture
supernatants collected 18 hours later were analysed by ELISA for TNF-α. Murine bone
marrow derived macrophages were also stimulated with either LPS (c) or CD40L/IFN-γ
[CI] (d) with added NN or NT and culture supernatants tested for NO by the Griess reaction.
*** p ≤0.0001, ** p ≤0.002, * p ≤0.02.error bars =SEM.
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Figure 5. Alpha defensins are one of the the active anti-inflammatory factors released by
apoptotic/necrotic neutrophils
LPS (a) or CI (b) stimulated HMDM were cultured with NN, NN depleted of hydrophobic
molecules by R2 beads (NN-R2) and NN-R2 where α-defensins were added back at 25ug/
ml [(NN-R2)+AD]. Culture supernatants were collected after 18 hours of culture and tested
for TNF-α secretion by ELISA. (c) A protein gel of NN indicated the large number of
proteins released by necrotic neutrophils (NN). NN were depleted of hydrophobic proteins
by R2 beads (NN-R2) and the proteins bound to the R2 beads (R2) were identified. R2 beads
completely depleted a large band of small proteins between 3-5kD. This band was digested
and sequenced by HPLC and identified as the anti-microbial peptides, α-defensins. (d) The
actual release of α-defensins over 24 hours by cultured neutrophils undergoing apoptosis
was quantified by HNP 1-3 ELISA. (e) To ensure that the R2 beads had not depleted other
anti-inflammatory factors, α-defensins in NN were specifically depleted using anti-HNP
antibodies bound to dynabeads. HMDMs were then stimulated with CI or LPS along with
added NN depleted of α-defensins (NN-α def) or depleted NN where HNP 1-3 has been
added back at 25ug/ml (NN-α def)+HNP. As an additional control HMDMs were stimulated
with CI or LPS in the presence of the D-enantiomer of HNP1-3, which lacks anti-
inflammatiory activity and is protease resistant.. *** p ≤0.0001, ** p ≤0.04. error bars
=SEM.
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Fig 6. Alpha defensins do not kill macrophages and actually enhance their phagocytic capacity
(a) HMDMs were pre-treated with HNP1-3 for 1 hour (i) and then allowed to rest for 1 (+/
1hr), 5 (+/5hr) or 20 hours (+/20hr) prior to stimulating them with LPS for a further 18
hours, after which supernatants were collected and tested for TNF-α by ELISA. (ii) The
same as (i) but HMDMs were pre-treated with HNP 1-3 for 24 hours and then rested for 24
(+/24hr), 48 (+/48hr) or 72 hours (+/72hr) prior to stimulating with LPS. Control HMDMs
were pre treated with vehicle alone for the same time period. (b)LDH levels were measured
from supernatants taken from HMDMs stimulated with CD40/IFN-γ (CI), HNP1-3 (HNP)
or cyclohexamide for 18 hours. (c) HMDMs were pre treated with HNP 1-3 or Puromycin
for 24 hours prior to stimulating with LPS for a further 18 hours. Alamar blue was used to
determine the the presence of reductive enzymes seen in viable cells. (d) Histograms of
HMDMs that were treated with vehicle (i), puromycin (ii) or HNP1-3 (iii) for 24 hours, prior
to adding fluorescent beads for 1 hour. Cells were washed, lifted from the cell culture plates
and the degree of eating quantified by FACs (black line). Dashed line represents control
HMDMs without added fluorescent beads. * p ≤0.01. error bars =SEM.
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Fig 7. Alpha defensins can still inhibit pro-inflammatory cytokine secretion by HMDMs despite
infection with whole bacteria
(a) HMDMs were co-cultured with dead Pseudomonas Aeruginosa PA01 for 24 hours (i) or
live bacteria (at an MOI of 10) for 4 hours (ii) after which culture supernatants were
collected and cytokine secretion quantitated by ELISA. (b) For the live bacterial experiment
HMDMs were lysed after 4 hours and bacteria cultured for a further 18 hours on agar prior
to counting the number of live colonies. (c) Mice were injected with 10×6 of live Salmonella
enterica serovar Typhimurium and PBS or NN was administered on days 0,1,2,4 and 6.
Mice were sacrificed on day 7 and TNF-α was measured in the serum (i). In addition the
number of live bacteria retrieved from lysed splenocytes after an overnight culture was
calculated following a further 18 hours of culture on agar (ii). *** p ≤0.0004, ** p ≤0.003, *
p ≤0.02. error bars =SEM
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Fig 8. Alpha defensins but not cathelicidins inhibit both T cell mediated and LPS mediated
activation of macrophages
HMDM were stimulated with either LPS (a) or CD40L/IFN-γ (CI) [b] and apoptotic
neutrophils (N), necrotic neutrophil supernatants (NN) or LL37 at the indicated doses. In
separate experiments HNP1-3 (c-d) or purified HNP-1 was titrated into CI or LPS activated
HMDMs. The anti-inflammatory potential of synthetically derived HNP-1 that had been
linearized was compared to α-defensins using CD40L/IFN-γ (CI) stimulated HMDMs.
Culture supernatants were harvested after 18 hours and tested for TNF-α secretion by
ELISA. *** p ≤0.0001, ** p ≤0.001, * p ≤0.01.error bars =SEM when compared to
HMDMs treated with stimulus alone .
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Figure 9. Alpha defensins do not inhibit the exocytosis of TNF-α
(a) HMDM were stimulated with CD40L/IFNγ (CI) either alone or in the presence of
HNP1-3 (25ug/ml) for the indicated times. TNF-α protein released by HMDMs was
measured by ELISA. (b) HMDMs were stimulated with LPS or CD40L/IFN-γ (CI) and
treated with HNP1-3 (25ug/ml) or vehicle alone. At 4 hours post stimulation culture
supernatants (i) were harvested prior to lysis of the HMDMs to reveal TNF-α retained
within the cells (ii). *** p ≤0.001, error bars =SEM.
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Figure 10. Necrotic neutrophils and α-defensins protect mice from experimental inflammation
Sterile peritonitis was induced by injecting thioglychollate, along with either PBS, apoptotic
cells (AC), necrotic human neutrophils (NN), LL37, HNP1-3 or mouse necrotic neutrophils
(mNN). After 4 hours peritoneal lavages were used to isolate inflammatory GR1+F480+
macrophages (a) and neutrophils (b), which were characterised by FACS and compared to
cell numbers in control mice with peritonitis given PBS. Experiment is representative of 2
separate expts with 5 mice per group. (c) In separate experiments resting murine peritoneal
macrophages were isolated and stimulated in vitro with CD40/IFN-γ along with α-defensins
and supernatants were collected at various timepoints and tested for TNF-α. *** p ≤0.001, *
p ≤0.01, error bars =SEM.
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